BioLineRx
Price & Volume
Stats
See moreOpen | $0.10 |
Previous Close | $0.10 |
Day Range | $0.10-$0.10 |
52W Range | $0.08-$1.44 |
Market Cap | $22.7M |
Shares Short | 822,212 |
Financials
See moreRevenue (12 Mos) | $17M |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $11M |
Diluted EPS | -$0.30 |
News
See moreYahoo Finance • 2 years ago
BioLineRx to Report First Quarter 2023 Results on May 24, 2023
Yahoo Finance • 2 years ago
BioLineRx Announces Publication in Nature Medicine of its GENESIS Phase 3 Clinical Trial Data Evaluating Motixafortide and G-CSF in Stem Cell Mobilization for Autologous Transplantation in Multiple Myeloma
Yahoo Finance • 2 years ago
BLRX 集體訴訟截止日期：業界領先的投資者權益法律事務所 ROSEN 鼓勵 BioLineRx Ltd. 投資者在本所提起證券集體訴訟的重要截止日期 3 月 6 日前尋求法律意見 – BLRX
About
Address | Modi?in Technology Park, Hevel Modi'in, Israel, 7177871 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 79 |
